Izba, Travatan, Travatan Z (travoprost) is a small molecule pharmaceutical. Travoprost was first approved as Izba on 2001-03-16. It is used to treat open-angle glaucoma in the USA. It has been approved in Europe to treat ocular hypertension and open-angle glaucoma. Travatan z's patents are valid until 2029-10-13 (FDA).
|Trade Name||Izba, Travatan|
|Indication||ocular hypertension, open-angle glaucoma|